Search Results - "Makus, Julia"

Insights into the Mechanism of Curaxin CBL0137 Epigenetic Activity: The Induction of DNA Demethylation and the Suppression of BET Family Proteins by Maksimova, Varvara, Popova, Valeriia, Prus, Anzhelika, Lylova, Evgeniya, Usalka, Olga, Sagitova, Guzel, Zhidkova, Ekaterina, Makus, Julia, Trapeznikova, Ekaterina, Belitsky, Gennady, Yakubovskaya, Marianna, Kirsanov, Kirill

“…The development of malignant tumors is caused by a complex combination of genetic mutations and epigenetic alterations, the latter of which are induced by…”
Get full text

Novel missense variants in brain morphogenic genes associated with depression and schizophrenia by Karagyaur, Maxim, Primak, Alexandra, Bozov, Kirill, Sheleg, Dmitriy, Arbatsky, Mikhail, Dzhauari, Stalik, Illarionova, Maria, Semina, Ekaterina, Samokhodskaya, Larisa, Klimovich, Polina, Velichko, Arkadiy, Drach, Mikhail, Sotskaya, Ekaterina, Popov, Vladimir, Rubina, Kseniya, Parfenenko, Mariia, Makus, Julia, Tsygankov, Boris, Tkachuk, Vsevolod, Neyfeld, Elena

“…Impaired function of brain morphogenic genes is considered one of the predisposing factors for the manifestation of psychiatric and cognitive disorders, such…”
Get full text

Histone Methyltransferases as a New Target for Epigenetic Action of Vorinostat by Maksimova, Varvara, Makus, Julia, Popova, Valeriia, Prus, Anzhelika, Usalka, Olga, Trapeznikova, Ekaterina, Zhidkova, Ekaterina, Belitsky, Gennady, Yakubovskaya, Marianna, Kirsanov, Kirill

“…Epigenetic genome regulation during malignant cell transformation is characterized by the aberrant methylation and acetylation of histones. Vorinostat (SAHA)…”
Get full text

EPIGENETIC EFFECTS OF ENZASTAURIN – A NEW ASPECT IN THE MECHANISM OF ACTION OF AN ANTICANCER DRUG FROM PROTEIN KINASE INHIBITORS by V. P. Maksimova, J. V. Makus, O. G. Usalka, E. S. Lylova, P. E. Bugaeva, E. M. Zhidkova, D. A. Fedorov, O. P. Lizogub, E. A. Lesovaya, G. A. Belitsky, M. G. Yakubovskaya, K. I. Kirsanov

“…The purpose of the study was to analyze the ability of five antitumor drugs from the pharmaceutical group of protein kinase inhibitors (gefitinib, imatinib,…”
Get full text